tiprankstipranks
Trending News
More News >
Bio-Techne (TECH)
NASDAQ:TECH
US Market
Advertisement

Bio-Techne (TECH) Earnings Dates, Call Summary & Reports

Compare
522 Followers

Earnings Data

Report Date
Feb 03, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.44
Last Year’s EPS
0.42
Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance for Bio-Techne. While there are significant challenges in biotech funding and revenue declines in specific segments, there are positive developments in large pharma growth, geographic expansion in China, and margin improvements. The company also made notable progress in sustainability and some product lines, but faces hurdles in cell therapy and biotech funding.
Company Guidance
During Bio-Techne's earnings call for the first quarter of fiscal year 2026, management provided guidance that reflected a disciplined approach to navigating a challenging market environment. The company reported a 1% decline in organic revenue, attributed primarily to timing issues with large customers in the cell therapy business and ongoing softness in biotech funding. Despite these headwinds, Bio-Techne achieved an adjusted operating margin of 29.9%, up 90 basis points year-over-year, and adjusted EPS remained flat at $0.42. Management highlighted robust demand from large pharma customers, low single-digit growth in EMEA and Asia, and a strong performance in China, particularly in the ProteinSimple instrument franchise. Looking forward, Bio-Techne anticipates continued headwinds in Q2 due to cell therapy dynamics but expects a return to positive organic growth in the second half of the fiscal year as market conditions improve and as they lap last year's challenging comparisons. The company remains on track to achieve at least 100 basis points of margin expansion for the full fiscal year.
Strong Large Pharma Growth
Revenue from large pharma customers increased in low double digits, reflecting continued demand for Bio-Techne's tools and technologies.
China Market Growth
China delivered its second consecutive quarter of growth, supported by improving CRO pipelines and increased CDMO activity.
Adjusted Operating Margin Expansion
Adjusted operating margin expanded by 90 basis points year-over-year to 29.9%, exceeding initial expectations.
ProteinSimple Instrument Momentum
The ProteinSimple instrument franchise showed strong utilization, with double-digit growth in cartridge consumable pull-through.
Sustainability Achievements
Bio-Techne achieved an estimated 40% reduction in Scope 1 and 2 emissions by transitioning to 100% renewable electricity at its largest site.

Bio-Techne (TECH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TECH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 03, 2026
2026 (Q2)
0.43 / -
0.42
Nov 05, 2025
2026 (Q1)
0.42 / 0.42
0.420.00% (0.00)
Aug 06, 2025
2025 (Q4)
0.50 / 0.53
0.498.16% (+0.04)
May 07, 2025
2025 (Q3)
0.51 / 0.56
0.4816.67% (+0.08)
Feb 05, 2025
2025 (Q2)
0.39 / 0.42
0.45.00% (+0.02)
Oct 30, 2024
2025 (Q1)
0.38 / 0.42
0.412.44% (+0.01)
Aug 07, 2024
2024 (Q4)
0.49 / 0.49
0.55-10.91% (-0.06)
May 01, 2024
2024 (Q3)
0.45 / 0.48
0.53-9.43% (-0.05)
Feb 01, 2024
2024 (Q2)
0.41 / 0.40
0.47-14.89% (-0.07)
Oct 31, 2023
2024 (Q1)
0.43 / 0.41
0.445-7.87% (-0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TECH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$61.10$59.94-1.90%
Aug 06, 2025
$54.56$49.80-8.72%
May 07, 2025
$47.57$48.60+2.17%
Feb 05, 2025
$72.24$74.92+3.71%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bio-Techne (TECH) report earnings?
Bio-Techne (TECH) is schdueled to report earning on Feb 03, 2026, Before Open (Confirmed).
    What is Bio-Techne (TECH) earnings time?
    Bio-Techne (TECH) earnings time is at Feb 03, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TECH EPS forecast?
          TECH EPS forecast for the fiscal quarter 2026 (Q2) is 0.44.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis